JP2011517929A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517929A5 JP2011517929A5 JP2010541633A JP2010541633A JP2011517929A5 JP 2011517929 A5 JP2011517929 A5 JP 2011517929A5 JP 2010541633 A JP2010541633 A JP 2010541633A JP 2010541633 A JP2010541633 A JP 2010541633A JP 2011517929 A5 JP2011517929 A5 JP 2011517929A5
- Authority
- JP
- Japan
- Prior art keywords
- bifidobacterium
- protein
- plasmid
- bacteria
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 39
- 230000000259 anti-tumor effect Effects 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 22
- 239000013612 plasmid Substances 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 18
- 230000010076 replication Effects 0.000 claims description 16
- 241000588724 Escherichia coli Species 0.000 claims description 15
- 239000013600 plasmid vector Substances 0.000 claims description 14
- 241000186000 Bifidobacterium Species 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000002243 precursor Substances 0.000 claims description 11
- 241001148471 unidentified anaerobic bacterium Species 0.000 claims description 9
- 102000000311 Cytosine Deaminase Human genes 0.000 claims description 6
- 108010080611 Cytosine Deaminase Proteins 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- 241000193403 Clostridium Species 0.000 claims description 4
- 241000194033 Enterococcus Species 0.000 claims description 4
- 241000186660 Lactobacillus Species 0.000 claims description 4
- 241000194017 Streptococcus Species 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 102000053187 Glucuronidase Human genes 0.000 claims description 3
- 108010060309 Glucuronidase Proteins 0.000 claims description 3
- 102000004459 Nitroreductase Human genes 0.000 claims description 3
- 108020001162 nitroreductase Proteins 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 2
- 238000001476 gene delivery Methods 0.000 claims description 2
- 239000013598 vector Substances 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 claims 5
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001131 transforming effect Effects 0.000 claims 2
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 229940118852 bifidobacterium animalis Drugs 0.000 claims 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims 1
- 229940004120 bifidobacterium infantis Drugs 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000013604 expression vector Substances 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12452808P | 2008-04-17 | 2008-04-17 | |
| US61/124,528 | 2008-04-17 | ||
| PCT/JP2009/001768 WO2009128272A1 (en) | 2008-04-17 | 2009-04-16 | Expression vector |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014248772A Division JP6089025B2 (ja) | 2008-04-17 | 2014-12-09 | 発現ベクター |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011517929A JP2011517929A (ja) | 2011-06-23 |
| JP2011517929A5 true JP2011517929A5 (enExample) | 2012-06-07 |
| JP5735804B2 JP5735804B2 (ja) | 2015-06-17 |
Family
ID=40792658
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541633A Active JP5735804B2 (ja) | 2008-04-17 | 2009-04-16 | 発現ベクター |
| JP2010541634A Active JP5514735B2 (ja) | 2008-04-17 | 2009-04-17 | 嫌気的疾患用治療薬 |
| JP2014248772A Active JP6089025B2 (ja) | 2008-04-17 | 2014-12-09 | 発現ベクター |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541634A Active JP5514735B2 (ja) | 2008-04-17 | 2009-04-17 | 嫌気的疾患用治療薬 |
| JP2014248772A Active JP6089025B2 (ja) | 2008-04-17 | 2014-12-09 | 発現ベクター |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8383398B2 (enExample) |
| EP (2) | EP2274422B1 (enExample) |
| JP (3) | JP5735804B2 (enExample) |
| KR (3) | KR101674977B1 (enExample) |
| CN (2) | CN102046791B (enExample) |
| CA (2) | CA2721653C (enExample) |
| DK (2) | DK2274422T3 (enExample) |
| ES (2) | ES2628378T3 (enExample) |
| HU (2) | HUE033561T2 (enExample) |
| PL (2) | PL2274422T3 (enExample) |
| PT (2) | PT2274422T (enExample) |
| WO (2) | WO2009128272A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8535939B2 (en) | 2010-01-29 | 2013-09-17 | Anaeropharma Science, Inc. | Transfection vector |
| US20130095072A1 (en) * | 2010-01-29 | 2013-04-18 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| EP2274422B1 (en) * | 2008-04-17 | 2017-03-15 | Anaeropharma Science, Inc. | Expression vector |
| US9730968B2 (en) | 2008-04-17 | 2017-08-15 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| US8338162B2 (en) * | 2009-04-17 | 2012-12-25 | Anaeropharma Science, Inc. | Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium |
| WO2013008881A1 (ja) * | 2011-07-13 | 2013-01-17 | 株式会社アネロファーマ・サイエンス | 虚血性疾患治療薬 |
| KR20170088866A (ko) | 2014-12-03 | 2017-08-02 | 가부시키가이샤 아네로파마·사이엔스 | 공발현 플라스미드 |
| KR101892722B1 (ko) * | 2015-01-19 | 2018-08-28 | 고쿠리츠 다이가쿠 호우징 신슈 다이가쿠 | 허혈성 질환 치료제 |
| LU100900B1 (de) * | 2018-08-10 | 2020-02-17 | Thomas Melchior Homann | Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen |
| WO2021038975A1 (ja) | 2019-08-28 | 2021-03-04 | 株式会社アネロファーマ・サイエンス | ダイアボディ型ＢｓＡｂを発現・分泌するビフィドバクテリウム属細菌 |
| CN112999215B (zh) * | 2019-12-20 | 2024-06-21 | 复旦大学 | 呋喃酮糖苷类化合物的应用 |
| CN115400154A (zh) * | 2022-08-10 | 2022-11-29 | 深圳未知君生物科技有限公司 | 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用 |
| WO2024187069A1 (en) * | 2023-03-08 | 2024-09-12 | University Of Florida Research Foundation, Incorporated | Engineering enterobacteria to site-specifically activate the anticancer prodrug 5-fluorocytosine for treating colon cancer |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8713601D0 (en) * | 1987-06-10 | 1987-07-15 | Unilever Plc | Fermentation |
| WO1991009131A1 (en) * | 1989-12-20 | 1991-06-27 | Valio Finnish Cooperative Dairies Association | Cloning vector for use in lactic acid bacteria |
| US6984513B2 (en) | 1994-03-03 | 2006-01-10 | The Board Of Trustees Of The Leland Stanford Junior University | Anaerobe targeted enzyme-mediated prodrug therapy |
| US6416754B1 (en) | 1994-03-03 | 2002-07-09 | The Board Of Trustees Of The Leland Stanford Junior University | Anaerobe targeted enzyme-mediated prodrug therapy |
| TW357191B (en) * | 1996-06-04 | 1999-05-01 | Food Industry Development Res Institute | Bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method the invention relates to bifidobacteria strains with acid, bile salt and oxygen tolerance and their culture method |
| JP2000060541A (ja) * | 1998-08-27 | 2000-02-29 | Fuyuki Mitsuyama | ビフィズス菌増殖促進物質と整腸物質とビフィズス菌製剤 |
| JP3642755B2 (ja) | 2000-09-21 | 2005-04-27 | 純 天野 | 嫌気性菌を用いた遺伝子治療用医薬 |
| CA2342040C (en) * | 2000-09-21 | 2012-07-10 | Kyowa Hakko Kogyo Co., Ltd. | Anaerobic bacterium as a drug for cancer gene therapy |
| US7008633B2 (en) * | 2000-12-18 | 2006-03-07 | Board Of Regents, The University Of Texas System | Local regional chemotherapy and radiotherapy using in situ hydrogel |
| KR100457879B1 (ko) * | 2001-02-24 | 2004-11-18 | 주식회사 비피도 | 비피도박테리움 유래 신규 플라스미드, 이를 이용한 재조합 발현 벡터 및 형질전환 방법 |
| PT2088193E (pt) | 2004-11-24 | 2011-02-24 | Anaeropharma Science Inc | Novo vector vaivém |
| ES2548516T3 (es) * | 2005-01-21 | 2015-10-19 | The Research Foundation Of The State University Of New York | Métodos para el tratamiento de la capsulitis adhesiva |
| EP1867714B1 (en) | 2005-04-08 | 2013-09-18 | Anaeropharma Science Inc. | 5-fluorouracil-resistant bacteria and method for production thereof |
| CA2646244A1 (en) * | 2006-03-27 | 2007-10-04 | Government Of The United States Of Americas, As Represented By The Secre | Tetracycline compounds and methods of treatment |
| GB2439310A (en) * | 2006-04-13 | 2007-12-27 | Ambrozea Inc | Fermentation residuals from genetically-modified microorganisms |
| JP5048661B2 (ja) | 2006-05-24 | 2012-10-17 | 株式会社アネロファーマ・サイエンス | 遺伝子輸送担体作製方法 |
| EP2274422B1 (en) * | 2008-04-17 | 2017-03-15 | Anaeropharma Science, Inc. | Expression vector |
-
2009
- 2009-04-16 EP EP09733074.0A patent/EP2274422B1/en active Active
- 2009-04-16 CA CA2721653A patent/CA2721653C/en active Active
- 2009-04-16 JP JP2010541633A patent/JP5735804B2/ja active Active
- 2009-04-16 KR KR1020107025821A patent/KR101674977B1/ko not_active Expired - Fee Related
- 2009-04-16 WO PCT/JP2009/001768 patent/WO2009128272A1/en not_active Ceased
- 2009-04-16 PT PT97330740T patent/PT2274422T/pt unknown
- 2009-04-16 ES ES09733074.0T patent/ES2628378T3/es active Active
- 2009-04-16 DK DK09733074.0T patent/DK2274422T3/en active
- 2009-04-16 CN CN2009801205839A patent/CN102046791B/zh active Active
- 2009-04-16 PL PL09733074T patent/PL2274422T3/pl unknown
- 2009-04-16 HU HUE09733074A patent/HUE033561T2/hu unknown
- 2009-04-16 US US12/425,001 patent/US8383398B2/en not_active Expired - Fee Related
- 2009-04-17 WO PCT/JP2009/001776 patent/WO2009128275A1/en not_active Ceased
- 2009-04-17 KR KR1020107025820A patent/KR101671283B1/ko not_active Expired - Fee Related
- 2009-04-17 EP EP09733604.4A patent/EP2280717B1/en active Active
- 2009-04-17 PT PT09733604T patent/PT2280717T/pt unknown
- 2009-04-17 CA CA2721664A patent/CA2721664C/en active Active
- 2009-04-17 US US12/988,181 patent/US8470311B2/en active Active
- 2009-04-17 DK DK09733604.4T patent/DK2280717T3/en active
- 2009-04-17 KR KR1020167022911A patent/KR20160102584A/ko not_active Ceased
- 2009-04-17 ES ES09733604.4T patent/ES2686080T3/es active Active
- 2009-04-17 CN CN2009801205843A patent/CN102046190B/zh active Active
- 2009-04-17 JP JP2010541634A patent/JP5514735B2/ja active Active
- 2009-04-17 PL PL09733604T patent/PL2280717T3/pl unknown
- 2009-04-17 HU HUE09733604A patent/HUE039768T2/hu unknown
-
2013
- 2013-01-24 US US13/749,428 patent/US20130122582A1/en not_active Abandoned
-
2014
- 2014-12-09 JP JP2014248772A patent/JP6089025B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011517929A5 (enExample) | ||
| JP2011518112A5 (enExample) | ||
| Lee et al. | Genomic insights into bifidobacteria | |
| EP3181682B1 (en) | Reduced colonization of microbes at the mucosa | |
| CN102046791B (zh) | 表达载体 | |
| CN102834514B (zh) | 转化用质粒 | |
| US20050276788A1 (en) | Self-containing lactobacillus strain | |
| Bansal et al. | Next generation sequencing, biochemical characterization, metabolic pathway analysis of novel probiotic Pediococcus acidilactici NCDC 252 and it’s evolutionary relationship with other lactic acid bacteria | |
| CN111205994B (zh) | 一株具核梭杆菌动物亚种菌株及其应用 | |
| US20220220489A1 (en) | Inducible plasmid-self-destruction assited recombination | |
| JP2007537741A (ja) | 自己収容性乳酸桿株 | |
| JP5871617B2 (ja) | 偏性嫌気性に変異化された乳酸菌およびその作製方法ならびに偏性嫌気性乳酸菌で機能する発現ベクター | |
| Matter et al. | Small multidrug resistance plasmids in Actinobacillus porcitonsillarum | |
| Wang et al. | Novel Bifidobacterium promoters selected through microarray analysis lead to constitutive high-level gene expression | |
| CN117551594A (zh) | 一种适用于具核梭杆菌转化的方法 | |
| EP1680508B1 (en) | Site-specific intestinal delivery and/or production of biologically active substances | |
| CN113817760B (zh) | 一种穿梭型食品级表达载体及其构建方法与应用 | |
| Sun et al. | The improvement of natural transformation procedure and the development of genome manipulation methods for Streptococcus thermophilus B-6 | |
| KR20250166255A (ko) | 비피도박테륨속 세균의 형질 전환 방법 | |
| HK1236565A1 (en) | Reduced colonization of microbes at the mucosa |